Request for Covid-19 Impact Assessment of this Report
The United States Anticoagulant Injections market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Anticoagulant Injections market, reaching US$ million by the year 2028. As for the Europe Anticoagulant Injections landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Anticoagulant Injections players cover Sanofi, Genentech (Roche), Boehringer Ingelheim, and Aspen, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Anticoagulant Injections market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
LMWH
Unfractionated Heparin
Fibrinolytics
Other
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
VTE
ACS/MI
AF
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Sanofi
Genentech (Roche)
Boehringer Ingelheim
Aspen
Pfizer
Hepalink
King-friend
CSBIO
Amphastar Pharmaceuticals
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Anticoagulant Injections Market Size 2017-2028
2.1.2 Anticoagulant Injections Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Anticoagulant Injections Segment by Type
2.2.1 LMWH
2.2.2 Unfractionated Heparin
2.2.3 Fibrinolytics
2.2.4 Other
2.3 Anticoagulant Injections Market Size by Type
2.3.1 Anticoagulant Injections Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Anticoagulant Injections Market Size Market Share by Type (2017-2022)
2.4 Anticoagulant Injections Segment by Application
2.4.1 VTE
2.4.2 ACS/MI
2.4.3 AF
2.4.4 Other
2.5 Anticoagulant Injections Market Size by Application
2.5.1 Anticoagulant Injections Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Anticoagulant Injections Market Size Market Share by Application (2017-2022)
3 Anticoagulant Injections Market Size by Player
3.1 Anticoagulant Injections Market Size Market Share by Players
3.1.1 Global Anticoagulant Injections Revenue by Players (2020-2022)
3.1.2 Global Anticoagulant Injections Revenue Market Share by Players (2020-2022)
3.2 Global Anticoagulant Injections Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Anticoagulant Injections by Regions
4.1 Anticoagulant Injections Market Size by Regions (2017-2022)
4.2 Americas Anticoagulant Injections Market Size Growth (2017-2022)
4.3 APAC Anticoagulant Injections Market Size Growth (2017-2022)
4.4 Europe Anticoagulant Injections Market Size Growth (2017-2022)
4.5 Middle East & Africa Anticoagulant Injections Market Size Growth (2017-2022)
5 Americas
5.1 Americas Anticoagulant Injections Market Size by Country (2017-2022)
5.2 Americas Anticoagulant Injections Market Size by Type (2017-2022)
5.3 Americas Anticoagulant Injections Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anticoagulant Injections Market Size by Region (2017-2022)
6.2 APAC Anticoagulant Injections Market Size by Type (2017-2022)
6.3 APAC Anticoagulant Injections Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Anticoagulant Injections by Country (2017-2022)
7.2 Europe Anticoagulant Injections Market Size by Type (2017-2022)
7.3 Europe Anticoagulant Injections Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Anticoagulant Injections by Region (2017-2022)
8.2 Middle East & Africa Anticoagulant Injections Market Size by Type (2017-2022)
8.3 Middle East & Africa Anticoagulant Injections Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Anticoagulant Injections Market Forecast
10.1 Global Anticoagulant Injections Forecast by Regions (2023-2028)
10.1.1 Global Anticoagulant Injections Forecast by Regions (2023-2028)
10.1.2 Americas Anticoagulant Injections Forecast
10.1.3 APAC Anticoagulant Injections Forecast
10.1.4 Europe Anticoagulant Injections Forecast
10.1.5 Middle East & Africa Anticoagulant Injections Forecast
10.2 Americas Anticoagulant Injections Forecast by Country (2023-2028)
10.2.1 United States Anticoagulant Injections Market Forecast
10.2.2 Canada Anticoagulant Injections Market Forecast
10.2.3 Mexico Anticoagulant Injections Market Forecast
10.2.4 Brazil Anticoagulant Injections Market Forecast
10.3 APAC Anticoagulant Injections Forecast by Region (2023-2028)
10.3.1 China Anticoagulant Injections Market Forecast
10.3.2 Japan Anticoagulant Injections Market Forecast
10.3.3 Korea Anticoagulant Injections Market Forecast
10.3.4 Southeast Asia Anticoagulant Injections Market Forecast
10.3.5 India Anticoagulant Injections Market Forecast
10.3.6 Australia Anticoagulant Injections Market Forecast
10.4 Europe Anticoagulant Injections Forecast by Country (2023-2028)
10.4.1 Germany Anticoagulant Injections Market Forecast
10.4.2 France Anticoagulant Injections Market Forecast
10.4.3 UK Anticoagulant Injections Market Forecast
10.4.4 Italy Anticoagulant Injections Market Forecast
10.4.5 Russia Anticoagulant Injections Market Forecast
10.5 Middle East & Africa Anticoagulant Injections Forecast by Region (2023-2028)
10.5.1 Egypt Anticoagulant Injections Market Forecast
10.5.2 South Africa Anticoagulant Injections Market Forecast
10.5.3 Israel Anticoagulant Injections Market Forecast
10.5.4 Turkey Anticoagulant Injections Market Forecast
10.5.5 GCC Countries Anticoagulant Injections Market Forecast
10.6 Global Anticoagulant Injections Forecast by Type (2023-2028)
10.7 Global Anticoagulant Injections Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Anticoagulant Injections Product Offered
11.1.3 Sanofi Anticoagulant Injections Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Sanofi Main Business Overview
11.1.5 Sanofi Latest Developments
11.2 Genentech (Roche)
11.2.1 Genentech (Roche) Company Information
11.2.2 Genentech (Roche) Anticoagulant Injections Product Offered
11.2.3 Genentech (Roche) Anticoagulant Injections Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Genentech (Roche) Main Business Overview
11.2.5 Genentech (Roche) Latest Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Information
11.3.2 Boehringer Ingelheim Anticoagulant Injections Product Offered
11.3.3 Boehringer Ingelheim Anticoagulant Injections Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Boehringer Ingelheim Main Business Overview
11.3.5 Boehringer Ingelheim Latest Developments
11.4 Aspen
11.4.1 Aspen Company Information
11.4.2 Aspen Anticoagulant Injections Product Offered
11.4.3 Aspen Anticoagulant Injections Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Aspen Main Business Overview
11.4.5 Aspen Latest Developments
11.5 Pfizer
11.5.1 Pfizer Company Information
11.5.2 Pfizer Anticoagulant Injections Product Offered
11.5.3 Pfizer Anticoagulant Injections Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Pfizer Main Business Overview
11.5.5 Pfizer Latest Developments
11.6 Hepalink
11.6.1 Hepalink Company Information
11.6.2 Hepalink Anticoagulant Injections Product Offered
11.6.3 Hepalink Anticoagulant Injections Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Hepalink Main Business Overview
11.6.5 Hepalink Latest Developments
11.7 King-friend
11.7.1 King-friend Company Information
11.7.2 King-friend Anticoagulant Injections Product Offered
11.7.3 King-friend Anticoagulant Injections Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 King-friend Main Business Overview
11.7.5 King-friend Latest Developments
11.8 CSBIO
11.8.1 CSBIO Company Information
11.8.2 CSBIO Anticoagulant Injections Product Offered
11.8.3 CSBIO Anticoagulant Injections Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 CSBIO Main Business Overview
11.8.5 CSBIO Latest Developments
11.9 Amphastar Pharmaceuticals
11.9.1 Amphastar Pharmaceuticals Company Information
11.9.2 Amphastar Pharmaceuticals Anticoagulant Injections Product Offered
11.9.3 Amphastar Pharmaceuticals Anticoagulant Injections Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Amphastar Pharmaceuticals Main Business Overview
11.9.5 Amphastar Pharmaceuticals Latest Developments
12 Research Findings and Conclusion
Table 1. Anticoagulant Injections Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of LMWH
Table 3. Major Players of Unfractionated Heparin
Table 4. Major Players of Fibrinolytics
Table 5. Major Players of Other
Table 6. Anticoagulant Injections Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 7. Global Anticoagulant Injections Market Size by Type (2017-2022) & ($ Millions)
Table 8. Global Anticoagulant Injections Market Size Market Share by Type (2017-2022)
Table 9. Anticoagulant Injections Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Anticoagulant Injections Market Size by Application (2017-2022) & ($ Millions)
Table 11. Global Anticoagulant Injections Market Size Market Share by Application (2017-2022)
Table 12. Global Anticoagulant Injections Revenue by Players (2020-2022) & ($ Millions)
Table 13. Global Anticoagulant Injections Revenue Market Share by Player (2020-2022)
Table 14. Anticoagulant Injections Key Players Head office and Products Offered
Table 15. Anticoagulant Injections Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Anticoagulant Injections Market Size by Regions 2017-2022 & ($ Millions)
Table 19. Global Anticoagulant Injections Market Size Market Share by Regions (2017-2022)
Table 20. Americas Anticoagulant Injections Market Size by Country (2017-2022) & ($ Millions)
Table 21. Americas Anticoagulant Injections Market Size Market Share by Country (2017-2022)
Table 22. Americas Anticoagulant Injections Market Size by Type (2017-2022) & ($ Millions)
Table 23. Americas Anticoagulant Injections Market Size Market Share by Type (2017-2022)
Table 24. Americas Anticoagulant Injections Market Size by Application (2017-2022) & ($ Millions)
Table 25. Americas Anticoagulant Injections Market Size Market Share by Application (2017-2022)
Table 26. APAC Anticoagulant Injections Market Size by Region (2017-2022) & ($ Millions)
Table 27. APAC Anticoagulant Injections Market Size Market Share by Region (2017-2022)
Table 28. APAC Anticoagulant Injections Market Size by Type (2017-2022) & ($ Millions)
Table 29. APAC Anticoagulant Injections Market Size Market Share by Type (2017-2022)
Table 30. APAC Anticoagulant Injections Market Size by Application (2017-2022) & ($ Millions)
Table 31. APAC Anticoagulant Injections Market Size Market Share by Application (2017-2022)
Table 32. Europe Anticoagulant Injections Market Size by Country (2017-2022) & ($ Millions)
Table 33. Europe Anticoagulant Injections Market Size Market Share by Country (2017-2022)
Table 34. Europe Anticoagulant Injections Market Size by Type (2017-2022) & ($ Millions)
Table 35. Europe Anticoagulant Injections Market Size Market Share by Type (2017-2022)
Table 36. Europe Anticoagulant Injections Market Size by Application (2017-2022) & ($ Millions)
Table 37. Europe Anticoagulant Injections Market Size Market Share by Application (2017-2022)
Table 38. Middle East & Africa Anticoagulant Injections Market Size by Region (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Anticoagulant Injections Market Size Market Share by Region (2017-2022)
Table 40. Middle East & Africa Anticoagulant Injections Market Size by Type (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Anticoagulant Injections Market Size Market Share by Type (2017-2022)
Table 42. Middle East & Africa Anticoagulant Injections Market Size by Application (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Anticoagulant Injections Market Size Market Share by Application (2017-2022)
Table 44. Key Market Drivers & Growth Opportunities of Anticoagulant Injections
Table 45. Key Market Challenges & Risks of Anticoagulant Injections
Table 46. Key Industry Trends of Anticoagulant Injections
Table 47. Global Anticoagulant Injections Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 48. Global Anticoagulant Injections Market Size Market Share Forecast by Regions (2023-2028)
Table 49. Global Anticoagulant Injections Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 50. Global Anticoagulant Injections Market Size Market Share Forecast by Type (2023-2028)
Table 51. Global Anticoagulant Injections Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 52. Global Anticoagulant Injections Market Size Market Share Forecast by Application (2023-2028)
Table 53. Sanofi Details, Company Type, Anticoagulant Injections Area Served and Its Competitors
Table 54. Sanofi Anticoagulant Injections Product Offered
Table 55. Sanofi Anticoagulant Injections Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 56. Sanofi Main Business
Table 57. Sanofi Latest Developments
Table 58. Genentech (Roche) Details, Company Type, Anticoagulant Injections Area Served and Its Competitors
Table 59. Genentech (Roche) Anticoagulant Injections Product Offered
Table 60. Genentech (Roche) Main Business
Table 61. Genentech (Roche) Anticoagulant Injections Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. Genentech (Roche) Latest Developments
Table 63. Boehringer Ingelheim Details, Company Type, Anticoagulant Injections Area Served and Its Competitors
Table 64. Boehringer Ingelheim Anticoagulant Injections Product Offered
Table 65. Boehringer Ingelheim Main Business
Table 66. Boehringer Ingelheim Anticoagulant Injections Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 67. Boehringer Ingelheim Latest Developments
Table 68. Aspen Details, Company Type, Anticoagulant Injections Area Served and Its Competitors
Table 69. Aspen Anticoagulant Injections Product Offered
Table 70. Aspen Main Business
Table 71. Aspen Anticoagulant Injections Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 72. Aspen Latest Developments
Table 73. Pfizer Details, Company Type, Anticoagulant Injections Area Served and Its Competitors
Table 74. Pfizer Anticoagulant Injections Product Offered
Table 75. Pfizer Main Business
Table 76. Pfizer Anticoagulant Injections Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 77. Pfizer Latest Developments
Table 78. Hepalink Details, Company Type, Anticoagulant Injections Area Served and Its Competitors
Table 79. Hepalink Anticoagulant Injections Product Offered
Table 80. Hepalink Main Business
Table 81. Hepalink Anticoagulant Injections Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 82. Hepalink Latest Developments
Table 83. King-friend Details, Company Type, Anticoagulant Injections Area Served and Its Competitors
Table 84. King-friend Anticoagulant Injections Product Offered
Table 85. King-friend Main Business
Table 86. King-friend Anticoagulant Injections Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 87. King-friend Latest Developments
Table 88. CSBIO Details, Company Type, Anticoagulant Injections Area Served and Its Competitors
Table 89. CSBIO Anticoagulant Injections Product Offered
Table 90. CSBIO Main Business
Table 91. CSBIO Anticoagulant Injections Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 92. CSBIO Latest Developments
Table 93. Amphastar Pharmaceuticals Details, Company Type, Anticoagulant Injections Area Served and Its Competitors
Table 94. Amphastar Pharmaceuticals Anticoagulant Injections Product Offered
Table 95. Amphastar Pharmaceuticals Main Business
Table 96. Amphastar Pharmaceuticals Anticoagulant Injections Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 97. Amphastar Pharmaceuticals Latest Developments
List of Figures
Figure 1. Anticoagulant Injections Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Anticoagulant Injections Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Anticoagulant Injections Market Size Market Share by Type in 2021
Figure 7. Anticoagulant Injections in VTE
Figure 8. Global Anticoagulant Injections Market: VTE (2017-2022) & ($ Millions)
Figure 9. Anticoagulant Injections in ACS/MI
Figure 10. Global Anticoagulant Injections Market: ACS/MI (2017-2022) & ($ Millions)
Figure 11. Anticoagulant Injections in AF
Figure 12. Global Anticoagulant Injections Market: AF (2017-2022) & ($ Millions)
Figure 13. Anticoagulant Injections in Other
Figure 14. Global Anticoagulant Injections Market: Other (2017-2022) & ($ Millions)
Figure 15. Global Anticoagulant Injections Market Size Market Share by Application in 2021
Figure 16. Global Anticoagulant Injections Revenue Market Share by Player in 2021
Figure 17. Global Anticoagulant Injections Market Size Market Share by Regions (2017-2022)
Figure 18. Americas Anticoagulant Injections Market Size 2017-2022 ($ Millions)
Figure 19. APAC Anticoagulant Injections Market Size 2017-2022 ($ Millions)
Figure 20. Europe Anticoagulant Injections Market Size 2017-2022 ($ Millions)
Figure 21. Middle East & Africa Anticoagulant Injections Market Size 2017-2022 ($ Millions)
Figure 22. Americas Anticoagulant Injections Value Market Share by Country in 2021
Figure 23. Americas Anticoagulant Injections Consumption Market Share by Type in 2021
Figure 24. Americas Anticoagulant Injections Market Size Market Share by Application in 2021
Figure 25. United States Anticoagulant Injections Market Size Growth 2017-2022 ($ Millions)
Figure 26. Canada Anticoagulant Injections Market Size Growth 2017-2022 ($ Millions)
Figure 27. Mexico Anticoagulant Injections Market Size Growth 2017-2022 ($ Millions)
Figure 28. Brazil Anticoagulant Injections Market Size Growth 2017-2022 ($ Millions)
Figure 29. APAC Anticoagulant Injections Market Size Market Share by Region in 2021
Figure 30. APAC Anticoagulant Injections Market Size Market Share by Application in 2021
Figure 31. China Anticoagulant Injections Market Size Growth 2017-2022 ($ Millions)
Figure 32. Japan Anticoagulant Injections Market Size Growth 2017-2022 ($ Millions)
Figure 33. Korea Anticoagulant Injections Market Size Growth 2017-2022 ($ Millions)
Figure 34. Southeast Asia Anticoagulant Injections Market Size Growth 2017-2022 ($ Millions)
Figure 35. India Anticoagulant Injections Market Size Growth 2017-2022 ($ Millions)
Figure 36. Australia Anticoagulant Injections Market Size Growth 2017-2022 ($ Millions)
Figure 37. Europe Anticoagulant Injections Market Size Market Share by Country in 2021
Figure 38. Europe Anticoagulant Injections Market Size Market Share by Type in 2021
Figure 39. Europe Anticoagulant Injections Market Size Market Share by Application in 2021
Figure 40. Germany Anticoagulant Injections Market Size Growth 2017-2022 ($ Millions)
Figure 41. France Anticoagulant Injections Market Size Growth 2017-2022 ($ Millions)
Figure 42. UK Anticoagulant Injections Market Size Growth 2017-2022 ($ Millions)
Figure 43. Italy Anticoagulant Injections Market Size Growth 2017-2022 ($ Millions)
Figure 44. Russia Anticoagulant Injections Market Size Growth 2017-2022 ($ Millions)
Figure 45. Middle East & Africa Anticoagulant Injections Market Size Market Share by Region in 2021
Figure 46. Middle East & Africa Anticoagulant Injections Market Size Market Share by Type in 2021
Figure 47. Middle East & Africa Anticoagulant Injections Market Size Market Share by Application in 2021
Figure 48. Egypt Anticoagulant Injections Market Size Growth 2017-2022 ($ Millions)
Figure 49. South Africa Anticoagulant Injections Market Size Growth 2017-2022 ($ Millions)
Figure 50. Israel Anticoagulant Injections Market Size Growth 2017-2022 ($ Millions)
Figure 51. Turkey Anticoagulant Injections Market Size Growth 2017-2022 ($ Millions)
Figure 52. GCC Country Anticoagulant Injections Market Size Growth 2017-2022 ($ Millions)
Figure 53. Americas Anticoagulant Injections Market Size 2023-2028 ($ Millions)
Figure 54. APAC Anticoagulant Injections Market Size 2023-2028 ($ Millions)
Figure 55. Europe Anticoagulant Injections Market Size 2023-2028 ($ Millions)
Figure 56. Middle East & Africa Anticoagulant Injections Market Size 2023-2028 ($ Millions)
Figure 57. United States Anticoagulant Injections Market Size 2023-2028 ($ Millions)
Figure 58. Canada Anticoagulant Injections Market Size 2023-2028 ($ Millions)
Figure 59. Mexico Anticoagulant Injections Market Size 2023-2028 ($ Millions)
Figure 60. Brazil Anticoagulant Injections Market Size 2023-2028 ($ Millions)
Figure 61. China Anticoagulant Injections Market Size 2023-2028 ($ Millions)
Figure 62. Japan Anticoagulant Injections Market Size 2023-2028 ($ Millions)
Figure 63. Korea Anticoagulant Injections Market Size 2023-2028 ($ Millions)
Figure 64. Southeast Asia Anticoagulant Injections Market Size 2023-2028 ($ Millions)
Figure 65. India Anticoagulant Injections Market Size 2023-2028 ($ Millions)
Figure 66. Australia Anticoagulant Injections Market Size 2023-2028 ($ Millions)
Figure 67. Germany Anticoagulant Injections Market Size 2023-2028 ($ Millions)
Figure 68. France Anticoagulant Injections Market Size 2023-2028 ($ Millions)
Figure 69. UK Anticoagulant Injections Market Size 2023-2028 ($ Millions)
Figure 70. Italy Anticoagulant Injections Market Size 2023-2028 ($ Millions)
Figure 71. Russia Anticoagulant Injections Market Size 2023-2028 ($ Millions)
Figure 72. Spain Anticoagulant Injections Market Size 2023-2028 ($ Millions)
Figure 73. Egypt Anticoagulant Injections Market Size 2023-2028 ($ Millions)
Figure 74. South Africa Anticoagulant Injections Market Size 2023-2028 ($ Millions)
Figure 75. Israel Anticoagulant Injections Market Size 2023-2028 ($ Millions)
Figure 76. Turkey Anticoagulant Injections Market Size 2023-2028 ($ Millions)
Figure 77. GCC Countries Anticoagulant Injections Market Size 2023-2028 ($ Millions)
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...